肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

2022 ABS共识声明：肝脏肿瘤钇90微球永久性植入近距离放射治疗

2022-05-19 美国近距离放疗学会 Brachytherapy

肝脏肿瘤近距离放射治疗钇90微球

2022年5月，美国近距离放疗学会(ABS)发布了肝脏肿瘤钇90微球永久性植入近距离放射治疗共识声明。本文主要针对钇90（90Y）微球经动脉放射性栓塞近距离治疗肝癌和转移性肝癌达成多学科共识。

中文标题：

2022 ABS共识声明：肝脏肿瘤钇90微球永久性植入近距离放射治疗

英文标题：

The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors

发布机构：

美国近距离放疗学会

发布日期：

2022-05-19

简要介绍：

2022年5月，美国近距离放疗学会(ABS)发布了肝脏肿瘤钇90微球永久性植入近距离放射治疗共识声明。本文主要针对钇90（90Y）微球经动脉放射性栓塞近距离治疗肝癌和转移性肝癌达成多学科共识。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 ACLM专家共识声明：以缓解为目标的饮食干预治疗成人2型糖尿病.pdf)] GetToolGuiderByIdResponse(projectId=1, id=dbf7c1c002a4835f, title=2022 ABS共识声明：肝脏肿瘤钇90微球永久性植入近距离放射治疗, enTitle=The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors, guiderFrom=Brachytherapy, authorId=0, author=, summary=2022年5月，美国近距离放疗学会(ABS)发布了肝脏肿瘤钇90微球永久性植入近距离放射治疗共识声明。本文主要针对钇90（90Y）微球经动脉放射性栓塞近距离治疗肝癌和转移性肝癌达成多学科共识。, cover=https://img.medsci.cn/20220523/1653312011134_1608702.png, journalId=0, articlesId=null, associationId=1412, associationName=美国近距离放疗学会, associationIntro=, copyright=0, guiderPublishedTime=Thu May 19 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2022年5月，美国近距离放疗学会(ABS)发布了肝脏肿瘤钇90微球永久性植入近距离放射治疗共识声明。本文主要针对钇90（90Y）微球经动脉放射性栓塞近距离治疗肝癌和转移性肝癌达成多学科共识。</span></p>, tagList=[TagDto(tagId=3208, tagName=肝脏肿瘤), TagDto(tagId=81800, tagName=近距离放射治疗), TagDto(tagId=121584, tagName=钇90微球)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2919, appHits=24, showAppHits=0, pcHits=300, showPcHits=2894, likes=0, shares=8, comments=3, approvalStatus=1, publishedTime=Tue May 24 15:18:00 CST 2022, publishedTimeString=2022-05-19, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon May 23 21:23:42 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 16:38:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ACLM专家共识声明：以缓解为目标的饮食干预治疗成人2型糖尿病.pdf)])
2022 ACLM专家共识声明：以缓解为目标的饮食干预治疗成人2型糖尿病.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1225131, encodeId=b2db12251316b, content=提供的资料不对, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47c8195093, createdName=ms6000000491739637, createdTime=Wed Jun 08 08:35:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227527, encodeId=6f5e122e5276b, content=内容与题目不符哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f988100894, createdName=ms6000000586513511, createdTime=Mon Jun 20 11:58:27 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222317, encodeId=966c122231e50, content=文献下载错了哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db228155804, createdName=ms9000002108284352, createdTime=Wed May 25 14:30:45 CST 2022, time=2022-05-25, status=1, ipAttribution=)]
    2022-06-08 ms6000000491739637

    提供的资料不对

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1225131, encodeId=b2db12251316b, content=提供的资料不对, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47c8195093, createdName=ms6000000491739637, createdTime=Wed Jun 08 08:35:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227527, encodeId=6f5e122e5276b, content=内容与题目不符哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f988100894, createdName=ms6000000586513511, createdTime=Mon Jun 20 11:58:27 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222317, encodeId=966c122231e50, content=文献下载错了哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db228155804, createdName=ms9000002108284352, createdTime=Wed May 25 14:30:45 CST 2022, time=2022-05-25, status=1, ipAttribution=)]
    2022-06-20 ms6000000586513511

    内容与题目不符哦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1225131, encodeId=b2db12251316b, content=提供的资料不对, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47c8195093, createdName=ms6000000491739637, createdTime=Wed Jun 08 08:35:15 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227527, encodeId=6f5e122e5276b, content=内容与题目不符哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f988100894, createdName=ms6000000586513511, createdTime=Mon Jun 20 11:58:27 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222317, encodeId=966c122231e50, content=文献下载错了哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db228155804, createdName=ms9000002108284352, createdTime=Wed May 25 14:30:45 CST 2022, time=2022-05-25, status=1, ipAttribution=)]
    2022-05-25 ms9000002108284352

    文献下载错了哦

    0

相关指南

复杂性肝脏肿瘤三维可视化精准诊治专家共识

中华医学会数字医学分会 · 2017-01-30